This study presents placenta-derived mesenchymal stromal cell (PMSC) treatment as a potential therapy for Myelomeningocele (MMC).
Read the article here: www.ncbi.nlm.nih.gov
This study presents placenta-derived mesenchymal stromal cell (PMSC) treatment as a potential therapy for Myelomeningocele (MMC).
Read the article here: www.ncbi.nlm.nih.gov